Average Insider

Where insiders trade, we follow

Dianthus Therapeutics, Inc. /DE/ ($DNTH)
Accession: 0001992324-26-000004
Apr 1, 2026
๐Ÿ“ˆ Chart on TradingView๐Ÿ’ฐ Financials on Finviz
52W Low$13.37
Current$84.5694.8% above low, 5.2% below high
52W High$88.49

Filing Information

Accession Number0001992324-26-000004
Form Type4
Filing DateApr 1, 2026
DocumentView SEC Filing
Transactions
12
Total Shares
343,101
Total Value
$10,835,452.98

Transactions

NameTitleSecurityDerivativeTransaction DateTypeSharesPriceTotal CostShares AfterDirect/IndirectNature of OwnershipActions
Savitz Ryan
EVP, CFO & CBO
Common Stock
โ€”Mar 31, 2026Exercise/Conversion74,367$8.44$627,657.4874,367Directโ€”View Details
Savitz Ryan
EVP, CFO & CBO
Common Stock
โ€”Mar 31, 2026Exercise/Conversion40,000$17.88$715,200.00114,367Directโ€”View Details
Savitz Ryan
EVP, CFO & CBO
Common Stock
โ€”Mar 31, 2026Sale1,390$78.33$108,878.70112,977Directโ€”View Details
Savitz Ryan
EVP, CFO & CBO
Common Stock
โ€”Mar 31, 2026Sale21,825$78.86$1,721,119.5091,152Directโ€”View Details
Savitz Ryan
EVP, CFO & CBO
Common Stock
โ€”Mar 31, 2026Sale1,485$80.25$119,171.2589,667Directโ€”View Details
Savitz Ryan
EVP, CFO & CBO
Common Stock
โ€”Mar 31, 2026Sale800$81.36$65,088.0088,867Directโ€”View Details
Savitz Ryan
EVP, CFO & CBO
Common Stock
โ€”Mar 31, 2026Sale2,366$82.84$195,999.4486,501Directโ€”View Details
Savitz Ryan
EVP, CFO & CBO
Common Stock
โ€”Mar 31, 2026Sale59,800$83.90$5,017,220.0026,701Directโ€”View Details
Savitz Ryan
EVP, CFO & CBO
Common Stock
โ€”Mar 31, 2026Sale19,469$84.57$1,646,493.337,232Directโ€”View Details
Savitz Ryan
EVP, CFO & CBO
Common Stock
โ€”Mar 31, 2026Sale7,232$85.54$618,625.280Directโ€”View Details
Savitz Ryan
EVP, CFO & CBO
Stock Option (Right to Buy)
(Common Stock)
DerivativeMar 31, 2026Exercise/Conversion74,367$0.00$0.0010,399Directโ€”View Details
Savitz Ryan
EVP, CFO & CBO
Stock Option (Right to Buy)
(Common Stock)
DerivativeMar 31, 2026Exercise/Conversion40,000$0.00$0.0080,000Directโ€”View Details
Version: v26.3.33